(NYSE: ALB) Albemarle's forecast annual revenue growth rate of 11.9% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.07%.
Albemarle's revenue in 2026 is $4,946,415,000.On average, 27 Wall Street analysts forecast ALB's revenue for 2026 to be $621,913,801,360, with the lowest ALB revenue forecast at $454,430,201,940, and the highest ALB revenue forecast at $755,853,601,880. On average, 20 Wall Street analysts forecast ALB's revenue for 2027 to be $714,070,975,180, with the lowest ALB revenue forecast at $529,756,627,540, and the highest ALB revenue forecast at $946,288,221,600.
In 2028, ALB is forecast to generate $835,887,929,080 in revenue, with the lowest revenue forecast at $811,053,748,140 and the highest revenue forecast at $869,078,635,360.